Skip to main content
Signal8

Item 9 Labs Corp. (INLB)

Sector: Drug Manufacturers - Specialty & Generic

Industry: Drug Manufacturers - Specialty & Generic

Item 9 Labs Corp. logo

Item 9 Labs Corp.

OTC:INLBHealthcare
CLOSED
Mkt Cap-
EV-
Float524.14M
O/S701.81M
VOL400 sh
RVOL1.00×
Inst Own-
Net Cash/Sh-
EarningsDec 2 · in 2w
Dilution
Historical Data
DateOpenHighLowCloseVolume
Oct 26, 20260.00000.00000.00000.0000400
Oct 2, 20260.00000.00000.00000.0000350
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
About

Based in the United States, Item 9 Labs Corp. operates as a comprehensive cannabis company, encompassing both vertical integration in cannabis operations and the franchising of dispensaries.

The firm produces a wide spectrum of cannabis and related goods, such as raw flower, various concentrates, distillates, and necessary hardware. These cannabis and derived technologies and products are then supplied to consumers in Arizona via licensed retail dispensaries. Complementing its production activities, the company also develops and offers medical and adult-use cannabis dispensary franchises under its distinct Unity Rd brand. The main office for Item 9 Labs Corp. is found in Phoenix, Arizona.

Key Metrics
Market Cap--
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--

based on 701.81M shares outstanding

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ExchangeOTC
CountryUSUS
IPO DateJan 25, 2012
Shares Outstanding701.81M
Authorized Shares
Float524.14M
52-Week Range
Volume
Average Daily Volume400

30d Avg

400

60d Avg

375

90d Avg

383

Earnings
Dividend History
No dividend history available